Abstract
Pharmacology, Toxicology and Biomedical Reports,2019,5,3s,S35-S39.DOI:10.5530/PTB.2019.5.35Published:September 2019Type:Research ArticleAuthors:Yousef Ahmed Alomi, Mona Awad Alanazi, and Faiz A. Bahadig Author(s) affiliations:Yousef Ahmed Alomi*, The Former General Manager of General Administration of Pharmaceutical Care. Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Mona Awad Alanazi, IV admixture and TPN units, Pharmacy services, Prince Mohammad Bin Abdulaziz Hospital Riyadh, SAUDI ARABIA. Faiz A. Bahadig, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA. Abstract:Objectives: In 2013, The General Administration of Pharmaceutical Care started the National Total Parenteral Nutrition (TPN) Program in Saudi Arabia. The pharmacist can provide neonates’ TPN services. In this study, we aimed to estimate the economic outcomes and cost avoidance in relation to pharmacist prescribing TPN. Methods: A total of 20 hospitals provide TPN services for neonates, pediatrics and adult patients. Cost avoidance stimulation in relation to the pharmacist prescribing and running neonates, pediatrics TPN services and replacement physician of a pharmacist as prescriber with adults TPN services. All costs were calculated by using US dollar currency. One-way sensitivity analysis was conducted for a list of discount prices and variety of wage cost with 10–20%. Results: The total annual estimated cost avoidance of pharmacist by providing TPN services for 20 hospitals for all types of patients was (1,569,865.40 USD) and with a discount of 10-20%, it was (1,412,878.86-1,255,892.32 USD). Of those, the total annual estimated cost avoidance of pharmacist providing the TPN services for 20 hospitals for neonates was (562,027.40 USD) and with discount of 10-20%, it was (505,824.66- 449,621.92 USD). The total annual estimated cost avoidance of pharmacist providing the TPN services for 20 hospitals for adults was (523,337.00 USD) and with discount of 10-20%, it was (471,003.30- 418,669.60 USD). The total annual estimated cost avoidance of pharmacist providing the TPN services for 20 hospitals for pediatrics was (484,501.00 USD) and with a discount of 10-20%, it was (436,050.90- 387,600.80 USD). Conclusion: The pharmacist prescribing TPN prevents high economic burden on the healthcare system at Ministry of Health. Expanding the role of a pharmacist in the nutrition support services with an emphasis on prescribing TPN services is highly recommended at healthcare institutions in the Kingdom of Saudi Arabia. Keywords:Cost avoidance, Economic, Ministry of Health, Outcomes, Pharmacist, Prescribing, Saudi Arabia, Total Parenteral NutritionView:PDF (184.36 KB) PDF PDF Images Economic Outcomes of Pharmacist Prescribing Total Parenteral Nutrition at Ministry of Health in Saudi Arabia
Highlights
The pharmacy profession development quickly over the past years in the Kingdom of Saudi Arabia
To the best of our knowledge, there is no study about the cost avoidance by pharmacist prescribing and providing Total Parenteral Nutrition (TPN) services which has been published in Saudi Arabia, or the Gulf, or in the Middle Eastern countries.[11]
The estimated cost of TPN services running by the pharmacist for neonates was (786.74 US Dollars (USD))
Summary
The pharmacy profession development quickly over the past years in the Kingdom of Saudi Arabia. The pharmacist started working in the drug manufactures to only responsible for dispensing of medications. All pictures of pharmacy profession has dramatically changed after the concept of pharmaceutical care has changed.[1] It starts from patient assessment through medications dispensing and monitoring the drug-related problems after dispensing.[2] In recent years, pharmacists have started prescribing medications including Total Parenteral Nutrition (TPN).[3,4] The role of a pharmacist in the preparation and dispensing of TPN is well-known.[5] The clinical and economic impact of the pharmacist with TPN processes has been well studied by the local and international research groups.[6,7,8,9] the economic impact of the pharmacist prescribing TPN rarely investigated in practice[5,10] Few studies have investigated the role of the pharmacist in prescribing TPN with their impact and benefits.[6,7,11] To the best of our knowledge, there is no study about the cost avoidance by pharmacist prescribing and providing TPN services which has been published in Saudi Arabia, or the Gulf, or in the Middle Eastern countries.[11] very few the international investigation discussed the topic. In this study, we aimed to estimate economic outcomes and cost avoidance of pharmacist prescribing TPN in the KSA
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
